Ultima-Aromasin 25 – UltimaPharma
$80
Exemestane, an aromatase inhibitor, is used to reduce the amount of estrogen circulating in the body during an anabolic steroid cycle.
Description
Description
-
- Product and Laboratory: Aromasin (Exemestane) by Ultima Pharma
- Effects: Anti-estrogen, decreases fat build-up, decreases water retention
- Ingredients: Exemestane
- Form: Oral
- Concentration: 25 mg/tab
- Presentation: 50 tabs
- Dosage: 12.5-25 mg per day
Beginners Intermediate Advanced Female 12.5 mg per day 12.5-25 mg per day 12.5-25 mg per day N/A - Protection during treatment: N/A
- Pct post cycle therapy: N/A
- Stack: Turinabol / Proviron / Growth Hormone (All Varieties)
- Level: Intermediate
Buy Aromasin By Ultima Pharma – Exemestane 25mg Pills
Exemestane 25mg pills are among the best products you can administer to limit various negative estrogenic issues in an anabolic steroid cycle. Gynecomastia is perhaps the most common complication that occurs when estrogen levels rise in the body.
Lab Test

Shipped from WH Ultima Nakon World and Received in 12 to 16 days for $19(click for details)
- Our Warehouse Ultima Nakon World is shipping in the USA (New York, Los Angeles, Florida, North-Carolina, Texas…) and Worldwide.
- Brands available from our Warehouse ULTIMA NAKON WORLD : Ultima Pharma, Nakon Medical
- Shipping cost for our Warehouse Ultima Nakon World = $19(+15% of total order amount if you select our insurance)
- It takes usually within 5 working days (except weekend) after your order is paid to ship.
- After shipped, delivery in Europe (France, Italy, Germany, …) and in the rest of the world: 12 – 16 days
- Shipping tracking number is sent 3 days after shipped.
- We give particular attention to the packaging and delivery of all your products. Each shipment is treated with the utmost care. Our products are vacuum sealed to ensure protection, sterility, and especially incomparable discretion. We ship the products with their original packaging and instructions.
Reviews (0)






Reviews
There are no reviews yet.